Gene description for FLNA
Gene name filamin A
Gene symbol FLNA
Other names/aliases ABP-280
ABPX
CSBS
CVD1
FGS2
FLN
FLN-A
FLN1
FMD
MNS
NHBP
OPD
OPD1
OPD2
XLVD
XMVD
Species Homo sapiens
 Experiment description of studies that identified FLNA in Prostate cancer cells

1
Experiment ID138
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method
Mass spectrometry [QTOF]   Supporting data   MSS   
PubMed ID 22723089   
OrganismHomo sapiens
Experiment descriptionExosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
AuthorsHosseini-Beheshti E, Guns ES.
Journal name MCP
Publication year2012
SampleProstate cancer cells
Sample nameDU145 - Rep 2
Isolation/purification methodsSucrose density gradient
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry [QTOF]
EV-TRACK EV120018: EV-METRIC:38%

2
Experiment ID139
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method
Mass spectrometry [QTOF]   Supporting data   MSS   
PubMed ID 22723089   
OrganismHomo sapiens
Experiment descriptionExosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
AuthorsHosseini-Beheshti E, Guns ES.
Journal name MCP
Publication year2012
SampleProstate cancer cells
Sample nameDU145 - Rep 3
Isolation/purification methodsSucrose density gradient
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry [QTOF]
EV-TRACK EV120018: EV-METRIC:38%

3
Experiment ID140
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method
Mass spectrometry [QTOF]   Supporting data   MSS   
PubMed ID 22723089   
OrganismHomo sapiens
Experiment descriptionExosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
AuthorsHosseini-Beheshti E, Guns ES.
Journal name MCP
Publication year2012
SampleProstate cancer cells
Sample nameVCaP - Rep 2
Isolation/purification methodsSucrose density gradient
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry [QTOF]
EV-TRACK EV120018: EV-METRIC:38%

4
Experiment ID141
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method
Mass spectrometry [QTOF]   Supporting data   MSS   
PubMed ID 22723089   
OrganismHomo sapiens
Experiment descriptionExosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
AuthorsHosseini-Beheshti E, Guns ES.
Journal name MCP
Publication year2012
SampleProstate cancer cells
Sample nameVCaP - Rep 3
Isolation/purification methodsSucrose density gradient
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry [QTOF]
EV-TRACK EV120018: EV-METRIC:38%

5
Experiment ID277
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry [Q-TOF]
PubMed ID 22030351   
OrganismHomo sapiens
Experiment descriptionExpression of PTRF in PC-3 cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways
AuthorsInder KL, Zheng YZ, Davis MJ, Moon H, Loo D, Nguyen H, Clements JA, Parton RG, Foster LJ, Hill MM
Journal name MCP
Publication year2011
SampleProstate cancer cells
Sample namePC-3
Isolation/purification methodsDifferential centrifugation
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry [QTOF]
EV-TRACK -

6
Experiment ID887
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry
PubMed ID 25102470   
OrganismHomo sapiens
Experiment descriptionExamination of the specificity of tumor cell derived exosomes with tumor cells in vitro
AuthorsSmyth TJ, Redzic JS, Graner MW, Anchordoquy TJ.
Journal name Biochim Biophys Acta
Publication year2014
SampleProstate cancer cells
Sample namePC3
Isolation/purification methodsDifferential centrifugation
Ultracentrifugation
Density gradient centrifugation
Flotation density1.10-1.20 g/mL
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry
EV-TRACK EV140013: EV-METRIC:56%

7
Experiment ID963
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry
PubMed ID 25844599   
OrganismHomo sapiens
Experiment descriptionMolecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
AuthorsKharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, UlléA, Yachnin J, Nilsson S, Panaretakis T.
Journal name Oncotarget
Publication year2015
SampleProstate cancer cells
Sample nameDU145 Tax-Sen
Isolation/purification methodsDifferential centrifugation
Ultracentrifugation
Density gradient centrifugation
Flotation density1.12-1.19 g/mL
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry
Western blotting
EV-TRACK EV150027: EV-METRIC:11%, 56%

8
Experiment ID964
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry
PubMed ID 25844599   
OrganismHomo sapiens
Experiment descriptionMolecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
AuthorsKharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, UlléA, Yachnin J, Nilsson S, Panaretakis T.
Journal name Oncotarget
Publication year2015
SampleProstate cancer cells
Sample nameDU145 Tax-Res
Isolation/purification methodsDifferential centrifugation
Ultracentrifugation
Density gradient centrifugation
Flotation density1.13-1.18 g/mL
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry
Western blotting
EV-TRACK EV150027: EV-METRIC:11%, 56%

9
Experiment ID1110
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry
PubMed ID 24391718   
OrganismHomo sapiens
Experiment descriptionProteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
AuthorsDuijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pa.a-Toli. L, Jenster G.
Journal name PLoS One
Publication year2013
SampleProstate cancer cells
Sample namePC346C- replicate 1
Isolation/purification methodsDifferential centrifugation
Ultracentrifugation
Density gradient centrifugation
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry
EV-TRACK EV130038: EV-METRIC:33%

10
Experiment ID1111
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry
PubMed ID 24391718   
OrganismHomo sapiens
Experiment descriptionProteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
AuthorsDuijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pa.a-Toli. L, Jenster G.
Journal name PLoS One
Publication year2013
SampleProstate cancer cells
Sample namePC346C- replicate 2
Isolation/purification methodsDifferential centrifugation
Ultracentrifugation
Density gradient centrifugation
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry
EV-TRACK EV130038: EV-METRIC:33%

11
Experiment ID1113
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry
PubMed ID 24391718   
OrganismHomo sapiens
Experiment descriptionProteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
AuthorsDuijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pa.a-Toli. L, Jenster G.
Journal name PLoS One
Publication year2013
SampleProstate cancer cells
Sample nameVCaP- replicate 1
Isolation/purification methodsDifferential centrifugation
Ultracentrifugation
Density gradient centrifugation
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry
EV-TRACK EV130038: EV-METRIC:33%

12
Experiment ID1260
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry
PubMed ID 24371517   
OrganismHomo sapiens
Experiment descriptionExosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
AuthorsBijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR.
Journal name J Extracell Vesicles.
Publication year2013
SampleProstate cancer cells
Sample nameLNCaP
Isolation/purification methodsDifferential centrifugation
Ultracentrifugation
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry
Western blotting
EV-TRACK EV130168: EV-METRIC:11%, 11%

13
Experiment ID1261
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Mass spectrometry
PubMed ID 24371517   
OrganismHomo sapiens
Experiment descriptionExosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
AuthorsBijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR.
Journal name J Extracell Vesicles.
Publication year2013
SampleProstate cancer cells
Sample namePC3
Isolation/purification methodsDifferential centrifugation
Ultracentrifugation
Flotation density-
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry
Western blotting
EV-TRACK EV130168: EV-METRIC:11%, 11%

<